ATYPICAL FEMORAL FRACTURES AFTER TREATMENT WITH BISPHOSPHONATES AND DENOSUMAB IN INFLAMMATORY AND SENILE OSTEOPOROSIS

被引:1
|
作者
Melendez, L. Merino [1 ]
Llorente, I. [1 ]
Garcia, E. [1 ]
Garcia-Vicuna, R. [1 ]
Sanz, S. Castaneda [1 ]
机构
[1] Hosp Univ la Princesa, Rheumatol, Madrid, Spain
关键词
D O I
10.1136/annrheumdis-2015-eular.5000
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0288
引用
收藏
页码:762 / 763
页数:2
相关论文
共 50 条
  • [1] ATYPICAL FEMORAL FRACTURES IN PATIENTS WITH OSTEOPOROSIS TREATED WITH DENOSUMAB OR BISPHOSPHONATES
    Everts-Graber, J.
    Bonel, H.
    Lehmann, D.
    Gahl, B.
    Hauselmann, H.
    Studer, U.
    Ziswiler, H. R.
    Reichenbach, S.
    Lehmann, T.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S316 - S316
  • [2] Denosumab and atypical femoral fractures
    Aspenberg, Per
    ACTA ORTHOPAEDICA, 2014, 85 (01) : 1 - 1
  • [3] Bisphosphonates and Atypical Femoral Fractures
    Hofbauer, Lorenz C.
    Jakob, Franz
    Felsenberg, Dieter
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1084 - 1084
  • [4] Bisphosphonates and atypical femoral fractures
    Adler, Robert A.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2016, 23 (06) : 430 - 434
  • [5] Bisphosphonates and Atypical Femoral Fractures
    Corrarino, Jane E.
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (04): : 389 - 396
  • [6] Atypical Femoral Fractures and Bisphosphonates Treatment: Is it a Risk Factor?
    Geada, Nuno
    Mafra, Ines
    Barroso, Rogerio
    Franco, Jose
    ACTA MEDICA PORTUGUESA, 2014, 27 (06) : 704 - 709
  • [7] Atypical femoral fractures and bisphosphonates Reply
    Alwahhabi, Basmah K. S.
    SAUDI MEDICAL JOURNAL, 2017, 38 (08) : 872 - 872
  • [8] Atypical Fractures of the Femur Related to Prolonged Treatment with Bisphosphonates for Osteoporosis
    Rosenthal, Yoav
    Arami, Amir
    Kosashvili, Yona
    Cohen, Nir
    Sidon, Eli
    Velkes, Steven
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (02): : 78 - 82
  • [9] Atypical femur fractures associated with use of bisphosphonates and denosumab
    Farooki, A.
    Fornier, M.
    Boland, P.
    ANNALS OF ONCOLOGY, 2015, 26 (04) : 819 - 820